EQS-News

Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024 - Seite 3

“Despite the first quarter traditionally being the weakest in our fiscal year, we achieved a positive result. We are therefore confident that we will achieve our forecast for the year,” says Stefan Dräger.

Further information is available in the financial report at www.draeger.com.

Disclaimer
This press release contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company’s knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company’s influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Information on the financial indicators used (incl. alternative performance measures) can be found on our corporate website www.draeger.com in our Investor Relations section.

 

Key figures for the first quarter (€ million)	Q1 2024	Q1 2023	Change	Net of cur- rency effects
Order intake	810.8	803.8	+0.9	+1.5
Germany	212.1	200.7	+5.7	+5.7
Europe, Middle East, and Africa	312.0	288.8	+8.0	+7.9
Americas	160.4	143.4	+11.9	+10.8
Asia-Pacific	126.3	170.8	-26.1	-22.2
Order intake, medical division	453.7	465.3	-2.5	-1.9
Order intake, safety division	357.2	338.4	+5.5	+6.1
Net sales	735.8	761.1	-3.3	-2.6
Germany	170.0	162.4	+4.7	+4.7
Europe, Middle East, and Africa	301.8	281.2	+7.3	+7.2
Americas	156.5	160.1	-2.3	-2.7
Asia-Pacific	107.6	157.4	-31.7	-27.6
Net sales, medical division	417.4	469.9	-11.2	-10.4
Net sales, safety division	318.4	291.2	+9.3	+10.0
EBIT	15.1	29.1
EBIT margin	2.0	3.8
Earnings after income taxes	7.5	17.2
EBIT margin, medical division	-2.7	2.2
EBIT margin, safety division	8.3	6.5
Employees	16,476	16,284